InSite Vision has secured the new patent for its DuraSite 2 next-generation enhanced drug delivery system from the United States Patent and Trademark Office (USPTO). DuraSite 2's ability to significantly improve drug retention and ...
Tags: Insite Vision, Ophthalmic Drug
Aegis Therapeutics LLC, a US-based drug delivery technology company, has obtained New Zealand patent providing coverage through December 2029 for fast acting formulations of triptans. The New Zealand patent is the third patent awarded to ...
Tags: Aegis, Fast Acting Formulations
Injectable drug delivery components and systems developer and manufacturer WestPharmaceutical Services and its partner Daikyo Seiko in Tokyo, have commercially rolled out the Daikyo D4 elastomer stopper. WestPharmaceutical said that the ...
Medtronic, a US-based developer of medical devices, has introduced its new implantable neurostimulation systems, also called spinal cord stimulation (SCS) systems, for use in the treatment of chronic, intractable back and limb pain that are ...
Adamis Pharmaceuticals has signed an agreement to completely acquire 3M Company's MMM -0.36% Taper Dry Powder Inhaler (DPI) technology. Additionally, the company has entered into an agreement to exclusively license the platform technology ...
Tags: Adamis Pharmaceuticals, Dry Powder
Oral drug delivery systems developer Oramed Pharmaceuticals has submitted a pre-Investigational New Drug (pre-IND) seeking approval from the US Food and Drug Administration (FDA) to commence a trial on its orally ingestible exenatide ...
Depomed has acquired US and Canadian rights to Archimedes Pharma’s Lazanda (fentanyl) nasal spray for $4m in cash for pain management in cancer patients (BTPc) 18 years of age and older. Leveraging Archimedes patented PecSys drug ...
Tags: Pharma's Lazanda, Medicine
US-based dispensing systems supplier AptarGroup has announced plans to invest $26m to increase the capacity of its Aptar Stelmi pharma packaging business, which was acquired in July 2012. The investment will be used to expand facilities, ...
Tags: Aptargroup, Pharma Packaging
Alliqua, a US-based wound management and drug delivery company, is launching a preclinical proof-of-principal study of an experimental hydrogel transdermal patch containing lidocaine, in an effort to take advantage of the growing market for ...
Tags: Alliqua, Containing Lidocaine
US-based Aquavit Pharmaceuticals has inked a definitive licensing agreement with U-Bio Med, a South Korea-based medical technology device firm, for the global commercialization of its microneedle device technology. The agreement offers ...
Tags: Aquavit Inks, U-Bio Med, Microneedle Device Technology
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
Mott Corp has appointed Boris Levin as the company's new president and CEO, replacing Roger Klene who is retiring after 18 years. Levin was previously group president of Nypro Healthcare, serving the drug delivery, diagnostics, and surgical ...
Tags: Processing Machinery, Health, Medicine
InSite Vision has again secured the development rights for zithromycin ophthalmic solution 2%, trademarked as AzaSite Xtra, from Merck's subsidiary, Inspire Pharmaceuticals, in North America. According to the deal, a joint development ...
Tags: North America, InSite Vision, AzaSite Xtra
Teva Pharmaceutical Industries has signed an agreement to purchase pharmaceutical and drug delivery company, MicroDose Therapeutx, to strengthen its respiratory franchise. The deal involves acquisition of all of MicroDose's outstanding ...
Micell, a US-based biomedical company, has received CE (Conformité Européenne) Mark clearance for its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES). MiStent Sirolimus Eluting Absorbable ...
Tags: Micell, Mistent SES